Medical Cannabis Faces Double Standard for Safety, Efficacy Compared to Prescription Pills

Medical cannabis faces a double standard for safety and efficacy compared to prescription pharmaceuticals.

The most recent illustration of that fact is a story from the Wall Street Journal, which reported this week that at least a third of children with previously untreatable epilepsy got better on extracts of cannabis - a non-toxic botanical.

Of 75 children who took cannabidiol (CBD), the second most common active molecule in cannabis, “33% of them had their seizures drop by half,” the Journal reported.

In a study funded by GW Pharmaceuticals — makers of cannabis extract Epidiolex — 40 percent of patients saw seizures decline by more than half and 10 percent became "seizure-free.” 

A CBD-rich tincture faces a cultural double standard for safety and efficacy compared to much more powerful, and dangerous prescription medications for epilepsy.

Marijuana — a federally illegal schedule 1 drug with allegedly “no medical use” — temporarily cured one in ten...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.eastbayexpress.com/LegalizationNation/archives/2015/03/25/medical-cannabis-faces-double-standard-for-safety-efficacy-compared-to-prescription-pills